Introduction
Hepatocyte growth factor (HGF) is a mesenchyme-derived pleitrophic factor which regulates cell growth, cell motility, and morphogenesis of various types of cells (1) . HGF has been well characterized as a hepatotrophic and renotrophic factor in liver and kidney regeneration (2) (3) (4) . Recently, it was reported that HGF might play an important role as a member of endothelium-specific growth factors locally released to counteract endothelial cell dysfunction (4) . HGF level might be elevated in response to hypertension, acute myocardial infarction (5) , diabetes mellitus with hypertensive complications (6) and peripheral arterial occlusive diseases (7) . These findings suggest that serum HGF could be used as a diagnostic marker related to the progression of clinically overt atherosclerosis. However, there is little knowledge about the relation between serum HGF and carotid atherosclerosis (8) .
In this study, to test the hypothesis that serum HGF level could be associated with carotid atherosclerosis, we investigated the potential role of serum HGF in patients with carotid atherosclerotic changes without overt liver, kidney, or lung damage.
Materials and Methods

Subjects
Participants were consecutively enrolled from in-patients in the Medical Department of Nomura Municipal Hospital between August, 2000 and June, 2001. They underwent carotid ultrasound evaluation for possible atherosclerosis. Subjects who were free of cardiac, liver and renal diseases, in addition to lung diseases, were enrolled in the study. Written informed consent for the procedure was obtained from each patient.
Ultrasound image analysis
An ultrasonograph (Hitachi EUB-565) equipped with a 7.5 MHz linear type B-mode probe was used by a specialist in ultrasonography to evaluate sclerotic lesions of the common carotid arteries on the day closest to the day of blood biochemistry analyses (within 3 days). Patients were asked to assume the supine position, and the bilateral carotid arteries were observed obliquely from the front and rear directions. We measured the common carotid intima-media thickness (IMT) on the far wall of the bilateral common carotid artery at about 10 mm proximal to the bifurcation on the B-mode monitor, and used the mean values for study. Plaque was defined as a partially high echo of the intima-media complex or a protrusion into the lumen. Carotid atherosclerosis was defined as the carotid IMT > 1.0 mm (9).
Other risk factors
We measured systolic (SBP) and diastolic blood pressure (DBP) in the right upper arm of patients in a sedentary posture using an automatic oscillometric blood pressure recorder (UA-766, AND Co. Ltd, Tokyo, Japan). Cigarette smoking was quantified from daily consumption and duration of smoking. In the blood biochemistry analyses, total cholesterol (TC), HDL-cholesterol (HDL-C) and blood glucose were measured upon fasting within 2 days after admission. Sixty-six patients had been treated with anti-hypertensive drugs and six patients with antilipidemic drugs. All diabetic patients were defined as those who were diagnosed by the 75 g oral glucose tolerance test or those who previously had been treated with either sulfonylurea or insulin, in addition to diet. As for the presence of background atherosclerosis, those diagnosed as transient ischemic attack, cerebral infarction, angina pectoris, or myocardial infarction were placed in the disease group.
Measurement of serum HGF
The serum concentration of HGF was determined for each individual, using a specific enzyme-linked immunosorbent assay kit for human HGF (Otsuka Pharmaceutical Co. Ltd, Tokyo, Japan). The normal value for HGF reported by the manufacturer was less than 0.39 ng/ml (10).
Statistical analysis
All values are expressed as means ± standard deviation (SD). Statistical analysis was performed using SPSS 10.0J software (Statistical Package for Social Science, Inc., Chicago, IL, USA). The prevalence among groups was compared by the chi-square test. The differences among groups were analyzed by the Kruskal-Wallis 1-Way ANOVA or Mann-Whitney U test. Analysis of covariance was employed to evaluate the difference of risk factor-carotid atherosclerosis interactions in serum HGF. A general linear model was employed to evaluate the significant contribution of risk factor-carotid atherosclerosis interactions for HGF. The relation between IMT and serum HGF concentration, gender (female: 0, male: 1), age, body mass index [BMI: body weight (kg)/height (m) 2 ], history of cigarettes × duration of smoking in years, SBP, DBP, anti-hypertensive drug use, TC, TG, HDL-C, antilipidemic drug use was examined by multiple regression analysis. A value of p < 0.05 was considered significant.
Results
Characteristics of subjects
The breakdown of the total 128 subjects (mean age, 74 ± 11 years) by gender was 48 males (72 ± 10 years) and 80 females (76 ± 12 years). Serum HGF concentration averaged 0.33 ng/ml (range, 0.12-0.96 ng/ml). The prevalence of diseases diagnosed among the subjects were 26 cases (20.3%) for stroke, 19 (14.8%) for diabetes mellitus, 17 (13.3%) for neurological disorders except for stroke, 15 (11.7%) for upper respiratory infection, 14 (10.9%) for infections, 13 (10.2%) for digestive diseases, 6 (4.7%) for hypertension, 6 (4.7%) for neoplasm, 4 (3.1%) for allergy or collagen diseases, 4 (3.1%) for metabolic disorders, and 4 (3.1%) for miscellaneous diseases. Table 1 shows their background factors classified by carotid atherosclerosis. The ratios of males, age, the incidence of plaque and the prevalence of ischemic stroke were higher in the group with carotid athersclerosis, but their DBP, HDL-C was significantly lower. There were no inter-group differences in background factors including BMI, smoking, SBP, anti-hypertensive drug use, TC, anti-lipidemic drug use, blood glucose, presence of diabetes mellitus, serum HGF concentration or the prevalence of ischemic heart disease.
Carotid atherosclerosis and serum HGF
The results showed a significantly positive correlation between serum HGF concentrations and age in patients with carotid atherosclerosis (IMT > 1.0 mm) (r = 0.391; p = 0.005). Although, there were no significant correlations between age and serum HGF concentrations in those without carotid atherosclerosis (IMT ≤ 1.0 mm) (r = 0.157; p = 0.173) (Fig. 1) . A general linear model analysis for HGF adjusted with other risk factors showed that the age-carotid atherosclerosis interactions were significantly associated with serum HGF (F [1.114] = 6.193; p = 0.014), in addition to age, SBP, aniti-hypertensive drug use, diabetes mellitus and carotid atherosclerosis ( Table  2 ). These findings suggest that serum HGF increased with aging and also with carotid atherosclerosis.
In contrast, multiple regression analysis showed that serum HGF (β = 0.160, p = 0.033) was independently associated with carotid atherosclerois, in addition to gender (β = 0.211, p = 0.019), age (β = 0.532, p < 0.001), SBP (β = 0.192, p = 0.023), and HDL-C (β = -0.208, p = 0.016) ( Table 3) .
Discussion
The circulating form of HGF has been used as a clinical marker for many target organs, such as lung, liver, kidney and brain (1, 11, 12) . Many studies to investigate their possible usefulness for measurement of the serum concentration of HGF as the indicator of atherosclerotic complications have been performed. Decreased local HGF production may promote the progression of arteriosclerotic vascular changes in diabetes mellitus (6) . On the other hand, HGF is synthesized in large amounts in the liver and secreted into the blood (13) . HGF is suggested to play a role in tissue regeneration (14) and systemic HGF may act as a humoral mediator in tissue regeneration, in addition to autocrine-paracrine local HGF production (1). The serum HGF concentration in untreated hypertensive patients was significantly higher than that in the normotensive group (15) , and serum HGF con- Values are means ± standard deviation. HDL, high-density lipoprotein. IMT, intima-media thickness. ✝ Smoking (pack-years) is expressed as the number of cigarettes per day × number of smoking years. *p-value was obtained by Mann-Whitney U test or chi-square test among two groups. Two cases showed both ischemic heart disease and ischemic stroke. centration in hypertensive or diabetic patients with complications was significantly higher than that in patients without complications (6, 15) . The circulating concentration of HGF has also been shown to be increased in coronary atherosclerosis (5, 16) , peripheral arterial occlusive disease (7) and proliferative diabetic retinopathy (17) . Namely, the serum HGF level reflects a degree of systemic vascular inflammation.
In the present study, we investigated the relation between serum HGF concentration and carotid atherosclerosis evaluated by ultrasonography in patients with risk factors. These results demonstrated that serum HGF increased with aging and also with carotid atherosclerosis, and that it was a significant explanatory factor for IMT thickening after adjustment for conventional risk factors. Although carotid IMT has been shown to reflect systemic atherosclerotic complications, ultrasonographic evaluation of the carotid artery is often used as a clinical marker of carotid atherosclerosis (18, 19) . Malatino et al. (20) also reported that serum HGF was an independent correlate to carotid IMT in 105 patients treated with hemodialysis and a marker of a process that contributes to the high morbidity and mortality. Yamamoto et al. (8) showed that plasma concentrations of HGF increased in relation to carotid arterial remodeling, independent of known risk factors for atheosclerosis. In the present study, we found that the elevation of serum HGF on age was significantly different between the presence/absence of carotid atherosclerosis. The slope of the linear regression on age was steeper in subjects with carotid atherosclerosis than in subjects without the carotid atherosclerosis, suggesting that the effect of an increase of HGF on age is more pronounced in subjects with carotid atherosclerosis. Although, carotid atherosclerosis has been demonstrated to be significantly associated with systemic atherosclerotic complications, we could not eliminate the A dominant model (IMT ≤ 0.1 mm = 0, IMT > 1.0 mm = 1) was used for carotid atherosclerosis . Various factors for the elevation of serum HGF in individuals with different clinical backgrounds have been reported. As for the relation between aging and serum HGF, many studies showed a strong positive correlation (1, 15, 21) . Serum HGF was also significantly associated with blood pressure and severity of hypertension (1, 15, 21) . However, the relation between SBP or diabetes mellitus and serum HGF is equivocal (6, 7, 16) . For example, Nakamura et al. (6) showed that serum HGF concentration in diabetes mellitus patients without hypertension was significantly lower than in normal subjects. In the present study, a general linear model for HGF adjusted with risk factors showed that serum HGF levels were significantly associated with age, SBP, anitihypertensive drug use, diabetes mellitus, carotid atherosclerosis, in addition to age-carotid atherosclerosis interaction. We need to be aware of the limitations for interpreting the present results. Since all participants were hospitalized patients, we could not eliminate the possibility of the effects of underlying diseases on the results. Although participants were free of cardiac, liver and renal disorders, in addition to lung diseases, 65 hypertensive patients, 28 diabetes patients and 6 patients with hyperlipidemia were treated, thus we could not eliminate the possible effects of medication on the present findings.
In summary, the present results suggest that serum HGF increases in relation to the development of carotid atherosclerosis, independent of known risk factors for atherosclerosis. These findings further support a possible role of HGF in atherosclerosis.
